Commonly encountered difficulties in pathologic staging of lung cancer

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 7, 2007, Pages 1016-1026

  Flieder, Douglas B ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHUS CANCER; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; DECISION MAKING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; MEDIASTINUM LYMPH NODE; PATHOLOGICAL ANATOMY; REVIEW;

BRONCHI; HUMANS; LUNG NEOPLASMS; LYMPH NODES; MEDIASTINUM; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PLEURA;

EID: 34447319134     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. American College of Surgeons Committee on Cancer. Cancer Program Standards: American College of Surgeons. Chicago, III: American College of Surgeons; 2003:38-39.
2. Mountain CF. A new international staging system for lung cancer. Chest. 1986;89(4 suppl):225S-233S.
3. Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710-1717.
4. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718-1723.
5. Lopez-Encuentra A, Bulzebruck H, Feinstein AR, et al. Tumor staging and classification in lung cancer: summary of the international symposium. Madrid, Spain, 3-4 December 1999. Lung Cancer. 2000;29:79-83.
6. Ginsberg RJ. Continuing controversies in staging NSCLC: an analysis of the revised 1997 staging system. Oncology (Williston Park). 1998;12(1 suppl 2):51-54.
7. Greene FL, for the American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
8. Rami-Porta R, Lopez-Encuentra A, Duque-Medina JL. Caution! The latest AJCC's rules for lung cancer classification differ from the latest UICC's. Lung Cancer. 2004;43:361-362.
9. Jackman DM, Johnson BE. Small-cell lung cancer. Lancet. 2005;366:1385-1396.
10. Lopez-Encuentra A, Garcia-Lujan R, Rivas JJ, Rodriguez-Rodriguez J, Torres-Lanza J, Varela-Simo G. Comparison between clinical and pathologic staging in 2,994 cases of lung cancer. Ann Thorac Surg. 2005;79:974-979.
11. D'Cunha J, Herndon JE II, Herzan DL, et al. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial. Lung Cancer. 2005;48:241-246.
12. Little AG, Rusch VW, Bonner JA, et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg. 2005;80:2051-2056.
13. Sobin LH, Wittekind C. International Union Against Cancer. TNM: Classification of Malignant Tumours. 6th ed. New York, NY: Wiley-Liss; 2002.
14. Rami-Porta R, Wittekind C, Goldstraw P. Complete resection in lung cancer surgery: proposed definition. Lung Cancer. 2005;49:25-33.
15. Allen MS. Mediastinal lymph node dissection for non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;130:241-242.
16. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol. 2003;21:1029-1034.
17. Doddoli C, Aragon A, Barlesi F, et al. Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer? Eur J Cardiothorac Surg. 2005;27:680-685.
18. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312:1604-1608.
19. Gephardt GN, Baker PB. Lung carcinoma surgical pathology report adequacy: a College of American Pathologists Q-Probes study of over 8300 cases from 464 institutions. Arch Pathol Lab Med. 1996;120:922-927.
20. Lung Protocol in the College of American Pathologists Cancer Protocols and Checklists. Available at: http://www.cap.org/apps/docs/cancer-protocols/ protocols-index.html. Accessed October 7, 2006.
21. Lung Carcinoma in ADASP Checklists and Guidelines for Surgical Pathology Reports of Malignant Neoplasms. Available at: http://www.adasp.org/Checklists/ checklists.htm. Accessed October 2, 2006.
22. Mark EJ. Normal microanatomy and biopsy Artifacts. In: Lung Biopsy Interpretation. Baltimore, Md: Williams & Wilkins; 1984:18-30.
23. American Joint Committee on Cancer Staging and End Results Reporting, American Cancer Society. Manual for Staging of Cancer, 1977. Chicago, Ill: American Joint Committee for Cancer Staging and End-Results Reporting; 1977.
24. Kato H, Tsuboi M, Kato Y, Ikeda N, Okunaka T, Hamada C. Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer. Int J Clin Oncol. 2005;10:157-164.
25. Shimizu K, Yoshida J, Nagai K, et al. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;130:160-165.
26. Shimizu K, Yoshida J, Nagai K, et al. Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment. J Thorac Cardiovasc Surg. 2004;127:1574-1578.
27. Satoh Y, Ishikawa Y, Inamura K, Okumura S, Nakagawa K, Tsuchiya E. Classification of parietal pleural invasion at adhesion sites with surgical specimens of lung cancer and implications for prognosis. Virchows Arch. 2005;447: 984-989.
28. Osaki T, Nagashima A, Yoshimatsu T, Yamada S, Yasumoto K. Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance. Ann Thorac Surg. 2004;77:1769-1773.
29. Bunker ML, Raab SS, Landreneau RJ, Silverman JF. The diagnosis and significance of visceral pleural invasion in lung carcinoma: histologic predictors and the role of elastic stains. Am J Clin Pathol. 1999;112:777-783.
30. Padilla J, Calvo V, Penalver JC, Sales G, Morcillo A. Surgical results and prognostic factors in early non-small cell lung cancer. Ann Thorac Surg. 1997; 63:324-326.
31. Nonaka M, Kataoka D, Yamamoto S, et al. Outcome following surgery for primary lung cancer with interlobar pleural invasion. Surg Today. 2005;35:22-27.
32. Miura H, Taira O, Uchida O, Kato H. Invasion beyond interlobar pleura in non-small cell lung cancer. Chest. 1998;114:1301-1304.
33. Okada M, Tsubota N, Yoshimura M, Miyamoto Y, Matsuoka H. How should interlobar pleural invasion be classified? Prognosis of resected T3 non-small cell lung cancer. Ann Thorac Surg. 1999;68:2049-2052.
34. Hammar SP. Common neoplasms. In: Dail DH, Hammar SP, eds. Pulmonary Pathology. New York, NY: Springer-Verlag; 1988:727-845.
35. Japan Lung Cancer Society. General Rule for Clinical and Pathological Record of Lung Cancer. 5th ed. Tokyo, Japan: Kanehara; 1999.
36. Manac'h D, Riquet M, Medioni J, Le Pimpec-Barthes F, Dujon A, Danel C. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor. Ann Thorac Surg. 2001;71:1088-1093.
37. Kang JH, Kim KD, Chung KY. Prognostic value of visceral pleura invasion in non-small cell lung cancer. Eur J Cardiothorac Surg. 2003;23:865-869.
38. Inoue M, Minami M, Shiono H, Sawabata N, Ideguchi K, Okumura M. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. J Thorac Cardiovasc Surg. 2006;131:988-993.
39. Butnor KJ, Cooper K. Visceral pleural invasion in lung cancer: recognizing histologic parameters that impact staging and prognosis. Adv Anat Pathol. 2005; 12:1-6.
40. Gallagher B, Urbanski SJ. The significance of pleural elastica invasion by lung carcinomas. Hum Pathol. 1990;21:512-517.
41. Dresler CM, Fratelli C, Babb J. Prognostic value of positive pleural lavage in patients with lung cancer resection. Ann Thorac Surg. 1999;67:1435-1439.
42. Goldstraw P, Lim E. Value of intraoperative pleural lavage in staging non-small cell lung cancer. J Thorac Cardiovasc Surg. 2004;128:331.
43. Ichinose Y, Yano T, Asoh H, Yokoyama H, Fukuyama Y, Katsuda Y. Diagnosis of visceral pleural invasion in resected lung cancer using a jet stream of saline solution. Ann Thorac Surg. 1997;64:1626-1629.
44. Lim E, Ali A, Theodorou P, Nicholson AG, Ladas G, Goldstraw P. Intraoperative pleural lavage cytology is an independent prognostic indicator for staging non-small cell lung cancer. J Thorac Cardiovasc Surg. 2004;127:1113-1118.
45. Riquet M, Badoual C, Le Pimpec Barthes F, et al. Visceral pleura invasion and pleural lavage tumor cytology by lung cancer: a prospective appraisal. Ann Thorac Surg. 2003;75:353-355.
46. Vicidomini G, Santini M, Pastore V. Intraoperative pleural lavage cytology should not influence decision for radical surgery in nonsmall cell lung cancer: reply. Ann Thorac Surg. 2005;80:1565.
47. Vicidomini G, Santini M, Fiorello A, Parascandolo V, Calabro B, Pastore V. Intraoperative pleural lavage: is it a valid prognostic factor in lung cancer? Ann Thorac Surg. 2005;79:254-257257.
48. Maruyama R, Shoji F, Okamoto T, et al. Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution. J Thorac Cardiovasc Surg. 2004;127:1587-1592.
49. D'Amico TA. Value of intraoperative pleural lavage in staging non-small cell lung cancer. J Thorac Cardiovasc Surg. 2004;127:947-948.
50. Fadel E, Yildizeli B, Chapelier AR, Dicenta I, Mussot S, Dartevelle PG. Sleeve lobectomy for bronchogenic cancers: factors affecting survival. Ann Thorac Surg. 2002;74:851-859.
51. Chunwei F, Weiji W, Xinguan Z, Qingzen N, Xiangmin J, Qingzhen Z. Evaluations of bronchoplasty and pulmonary artery reconstruction for bronchogenic carcinoma. Eur J Cardiothorac Surg. 2003;23:209-213.
52. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg. 1988;96:440-447.
53. Watanabe Y, Shimizu J, Oda M, et al. Early hilar lung cancer: its clinical aspect. J Surg Oncol. 1991;48:75-80.
54. Shimizu J, Watanabe Y, Oda M, et al. Evaluation of sleeve segmentectomy for early hilar lung cancer. Int Surg. 2002;87:53-59.
55. Terzi A, Pelosi G, Falezza G, Lonardoni A, Pasini F, Calabro F. Early hilar lung cancer - clinical aspects and long term survival: identification of a subgroup of stage IA patients with more favorable prognosis. Lung Cancer. 2000;27:119-124.
56. Maygarden SJ, Detterbeck FC, Funkhouser WK. Bronchial margins in lung cancer resection specimens: utility of frozen section and gross evaluation. Mod Pathol. 2004;17:1080-1086.
57. Massard G, Doddoli C, Gasser B, et al. Prognostic implications of a positive bronchial resection margin. Eur J Cardiothorac Surg. 2000;17:557-565.
58. Snijder RJ, Brutel de la Riviere A, Elbers HJ, van den Bosch JM. Survival in resected stage I lung cancer with residual tumor at the bronchial resection margin. Ann Thorac Surg. 1998;65:212-216.
59. Carey FA, Donnelly SC, Walker WS, Cameron EW, Lamb D. Synchronous primary lung cancers: prevalence in surgical material and clinical implications. Thorax. 1993;48:344-346.
60. Ferguson MK. Synchronous primary lung cancers. Chest. 1993;103(4 suppl):398S-400S.
61. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606-612.
62. Deslauriers J, Brisson J, Cartier R, et al. Carcinoma of the lung. Evaluation of satellite nodules as a factor influencing prognosis after resection. J Thorac Cardiovasc Surg. 1989;97:504-512.
63. Flieder DB, Vazquez M, Carter D, et al. Pathologic findings of lung tumors diagnosed on baseline CT screening. Am J Surg Pathol. 2006;30:606-613.
64. Nakata M, Sawada S, Yamashita M, et al. Surgical treatments for multiple primary adenocarcinoma of the lung. Ann Thorac Surg. 2004;78:1194-1199.
65. Beahrs OH, American Joint Committee on Cancer, American Cancer Society. Manual for Staging of Cancer. 4th ed. Philadelphia, Pa: Lippincott; 1992.
66. Roggli VL, Vollmer RT, Greenberg SD, McGavran MH, Spjut HJ, Yesner R. Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum Pathol. 1985;16:569-579.
67. Dacic S, Ionescu DN, Finkelstein S, Yousem SA. Patterns of allelic loss of synchronous adenocarcinomas of the lung. Am J Surg Pathol. 2005;29:897-902.
68. Shimizu S, Yatabe Y, Koshikawa T, et al. High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis. Clin Cancer Res. 2000;6:3994-3999.
69. Huang J, Behrens C, Wistuba I, Gazdar AF, Jagirdar J. Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis. Ann Diagn Pathol. 2001;5:321-329.
70. Hiroshima K, Toyozaki T, Kohno H, Ohwada H, Fujisawa T. Synchronous and metachronous lung carcinomas: molecular evidence for multicentricity. Pathol Int. 1998;48:869-876.
71. Garber ME, Troyanskaya OG, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A. 2001;98:13784-13789.
72. Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A. 2001;98:13790-13795.
73. Mountain CF. Invited commentary. Ann Thorac Surg. 1997;64:813.
74. Yoshino I, Nakanishi R, Osaki T, et al. Postoperative prognosis in patients with non-small cell lung cancer with synchronous ipsilateral intrapulmonary metastasis. Ann Thorac Surg. 1997;64:809-813.
75. Vansteenkiste JF, DeBelie B, Deneffe GJ, et al. Practical approach to patients presenting with multiple synchronous suspect lung lesions: a reflection on the current TNM classification based on 54 cases with complete follow-up. Lung Cancer. 2001;34:169-175.
76. Battafarano RJ, Meyers BF, Guthrie TJ, Cooper JD, Patterson GA. Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival. Ann Thorac Surg. 2002;74:988-993.
77. Ebright MI, Zakowski MF, Martin J, et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. Ann Thorac Surg. 2002;74:1640-1647.
78. Roberts PF, Straznicka M, Lara PN, et al. Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved. J Thorac Cardiovasc Surg. 2003;126:1597-1602.
79. Okada M, Tsubota N, Yoshimura M, Miyamoto Y, Nakai R. Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis. Ann Thorac Surg. 1999;68:326-331.
80. Urschel JD, Urschel DM, Anderson TM, Antkowiak JG, Takita H. Prognostic implications of pulmonary satellite nodules: are the 1997 staging revisions appropriate? Lung Cancer. 1998;21:83-91.
81. Ferguson MK, DeMeester TR, DesLauriers J, Little AG, Piraux M, Golomb H. Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg. 1985;89:378-385.
82. Zell JA, Ou SH, Ziogas A, Anton-Culver H. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol. 2005;23:8396-8405.
83. Mountain CF. The international system for staging lung cancer. Semin Surg Oncol. 2000;18:106-115.
84. Fukuse T, Hirata T, Tanaka F, Yanagihara K, Hitomi S, Wada H. Prognosis of ipsilateral intrapulmonary metastases in resected nonsmall cell lung cancer. Eur J Cardiothorac Surg. 1997;12:218-223.